• B&K Corporation appointed Jia Lijia as chief executive officer, effective October 20, 2026.
• Her term will end when the first board’s term expires.
• Jia founded the group in April 2012 and has over 27 years of pharmaceutical industry experience.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. B&K Corporation Limited published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261020-12377356), on October 20, 2026, and is solely responsible for the information contained therein.